Survival gain after liver transplantation for patients with alcoholic liver disease: A comparison across models and centers

Transplantation

Volumn 76, Issue 10, 2003, Pages 1479-1486

  Young, Tracey A ^a   Neuberger, James ^b   Longworth, Louise ^a   Ratcliffe, Julie ^a,c   Buxton, Martin J ^a  

^a BRUNEL UNIVERSITY   (United Kingdom)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALCOHOL LIVER DISEASE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MODEL; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL; TREATMENT OUTCOME;

BILIRUBIN; CREATININE; HUMANS; LIVER DISEASES, ALCOHOLIC; LIVER TRANSPLANTATION; MODELS, STATISTICAL; SERUM ALBUMIN; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 0345015358     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000089236.78772.57     Document Type: Article

References (27)

1. European Liver Transplant Registry web site. Available at: http://www.el-tr.org. Accessed March 2002.
2. Neuberger J, Lucey MR, eds. Liver transplantation: Practice and management. London, BMJ Publishing Group 1994.
3. Pocock SJ. Clinical trials: A practical approach. London, John Wiley and Sons 1983.
4. Clark DA, Stinson EB, Griepp RB, et al. Cardiac transplantation in man. VI. Prognosis of patients selected for cardiac transplantation. Ann Intern Med 1971; 75: 15.
5. O'Brien BJ, Buxton MJ, Ferguson BA. Measuring the effectiveness of heart transplant programmes: quality of life data and their relationship to survival analysis. J Chronic Dis 1987; 40(Suppl 1): 137S.
6. van Enkenvort PJ, Koopmanschap MA, Tenvergert EM, et al. Lifetime costs of lung transplantation: estimation of incremental costs. Health Econ 1997; 6: 479.
7. Gail MH. Does cardiac transplantation prolong life? A reassessment. Ann Intern Med 1972; 76: 815.
8. Bonsel GJ, Klompmaker IJ, van 'T Veer F, Habbema JD, et al. Use of prognostic models for assessment of value of liver transplantation in primary biliary cirrhosis. Lancet 1995; 335: 493.
9. Neuberger J, Altman DG, Christensen E, et al. Use of a prognostic index in evaluation of liver transplantation for primary biliary cirrhosis. Transplantation 1986; 41: 713.
10. Pugh RN, Murry-Lyon IM, Dawson JL, et al Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646.
11. Poynard T, Naveau S, Doffoel M, et al. Evaluation of efficacy of liver transplantation in alcoholic cirrhosis using matched and simulated controls. J Hepatol 1999; 30: 1130.
12. Poynard T, Barthelemy P, Fratte S, et al. Evaluation of efficacy of liver transplantation in alcoholic cirrhosis by a case-control study and simulated controls. Lancet 1994; 344: 502.
13. Anand AC, Ferraz-Neto BH, Nightingale P, et al. Liver transplantation for alcoholic liver disease: evaluation of a selection protocol. Hepatology 1997;25:1478.
14. Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31: 864.
15. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464.
16. Longworth L, Young T, Buxton MJ, et al. Mid-term cost-effectiveness of the liver transplantation programme of England and Wales for three disease groups. Liver Transplantation 2003 (in press).
17. Collett D. Modelling survival data in medical research: Texts in statistical science. London, Chapman and Hall 1994.
18. Rubin DB. Inference and missing data. Biometrica 1976; 63: 581.
19. Schafer JL. NORM: Multiple imputation of incomplete multivariate data under a normal model, version 2. Software for Windows 95/98/NT, 1999. Available at: http://www.stat.psu.edu/~jls/misoffwa.html. Accessed March 2002.
20. Mathsoft. S-PLUS 2000 Guide to Statistics, Vol. 1 and 2. Seattle, WA, Data Analysis Products Division 2000.
21. UK Transplant Activity Report 2001. Available at: www.uktransplant.org.uk/statiatics/transplant_activity/transplant_activity_uk. htm. Accessed May 2003.
22. United Network for Organ Sharing (UNOS). Annual report. Available at: http://www.optn.org/data/annualReport.asp. Accessed May 2003.
23. Clark T, Altman DG. Developing a prognostic model in the presence of missing data: an ovarian cancer case study. J Clin Epidemiol 2003; 56: 28.
24. Johnston K, Buxton MJ, Jones DR, et al. Assessing the costs of healthcare technologies in clinical trials. Health Technol Assess 1999; 3: 1.
25. Ratcliffe J, Young T, Buxton M, et al. A simulation modelling approach to evaluating alternative policies for the management of the waiting list for liver transplantation. Health Care Manag Sci 2001; 4: 117.
26. Altman DG, Royston P. What do we mean by validating a prognostic model? Stat Med 2000; 19: 453.
27. Schafer JL. Analysis of incomplete multivariate data. London, Chapman and Hall 1997.